![Twitter 上的Maladie de Crohn:"Pour moi... c'est sous forme de #stylo pour les #injections #sous #cutané d'#humira ! http://t.co/88ppbtQnxU" / Twitter Twitter 上的Maladie de Crohn:"Pour moi... c'est sous forme de #stylo pour les #injections #sous #cutané d'#humira ! http://t.co/88ppbtQnxU" / Twitter](https://pbs.twimg.com/media/BWOhXCMCYAE4sy7.jpg)
Twitter 上的Maladie de Crohn:"Pour moi... c'est sous forme de #stylo pour les #injections #sous #cutané d'#humira ! http://t.co/88ppbtQnxU" / Twitter
![STADA and Alvotech broaden European patients' options by launching Hukyndra® high-concentration, citrate-free adalimumab - Alvotech STADA and Alvotech broaden European patients' options by launching Hukyndra® high-concentration, citrate-free adalimumab - Alvotech](https://investors.alvotech.com/system/files-encrypted/nasdaq_kms/inline-images/Alvotech%20and%20Stada.png)
STADA and Alvotech broaden European patients' options by launching Hukyndra® high-concentration, citrate-free adalimumab - Alvotech
![Eindhoven, the Netherlands, 12th November 2019. Humira, adalimumab. A closed package containing a pen with a needle for a patient to inject themselves Stock Photo - Alamy Eindhoven, the Netherlands, 12th November 2019. Humira, adalimumab. A closed package containing a pen with a needle for a patient to inject themselves Stock Photo - Alamy](https://c8.alamy.com/comp/2AB3RRH/eindhoven-the-netherlands-12th-november-2019-humira-adalimumab-a-closed-package-containing-a-pen-with-a-needle-for-a-patient-to-inject-themselves-2AB3RRH.jpg)
Eindhoven, the Netherlands, 12th November 2019. Humira, adalimumab. A closed package containing a pen with a needle for a patient to inject themselves Stock Photo - Alamy
INFOS PRATIQUES HUMIRA® SOLUTION INJECTABLE PAR VOIE SOUS-CUTANÉE APPRENTISSAGE DE L'AUTO-INJECTION2 APPRENTISSAGE DE L
![Eindhoven, the Netherlands, 12th November 2019. Humira, adalimumab. A male hand holding a pen with a needle for a patient to inject themselves with to Stock Photo - Alamy Eindhoven, the Netherlands, 12th November 2019. Humira, adalimumab. A male hand holding a pen with a needle for a patient to inject themselves with to Stock Photo - Alamy](https://c8.alamy.com/comp/2AB3RT7/eindhoven-the-netherlands-12th-november-2019-humira-adalimumab-a-male-hand-holding-a-pen-with-a-needle-for-a-patient-to-inject-themselves-with-to-2AB3RT7.jpg)
Eindhoven, the Netherlands, 12th November 2019. Humira, adalimumab. A male hand holding a pen with a needle for a patient to inject themselves with to Stock Photo - Alamy
![HUMIRA® (adalimumab), produit d'AbbVie, est le premier et le seul médicament à recevoir l'approbation de Santé Canada pour le traitement de l'hidradénite suppurée modérée ou grave HUMIRA® (adalimumab), produit d'AbbVie, est le premier et le seul médicament à recevoir l'approbation de Santé Canada pour le traitement de l'hidradénite suppurée modérée ou grave](http://photos.newswire.ca/images/download/20160106_C6828_PHOTO_FR_592574.jpg)
HUMIRA® (adalimumab), produit d'AbbVie, est le premier et le seul médicament à recevoir l'approbation de Santé Canada pour le traitement de l'hidradénite suppurée modérée ou grave
![Eindhoven, the Netherlands, 12th November 2019. Humira, adalimumab. A man right after injecting himself in the leg with a pen and a needle to treat ps Stock Photo - Alamy Eindhoven, the Netherlands, 12th November 2019. Humira, adalimumab. A man right after injecting himself in the leg with a pen and a needle to treat ps Stock Photo - Alamy](https://c8.alamy.com/zooms/6/0df7dc9b94414c678aa62f4ab097beaa/2ab3rwb.jpg)